🔗 Permalink

Inventor profile of:

David C. Griffith

City:

San Marcos, California

Country:

United States

Published Applications:

Last publication date:

2025-02-27

Top Assignees for applications by David C. Griffith

The entities that hold a legal rights for patent applications filed by inventor Griffith David C.:

Mpex Pharmaceuticals, Inc. 10 San Diego, CA United States
HORIZON ORPHAN LLC 8 Lake Forest, IL United States
Rempex Pharmaceuticals, Inc. 7 San Diego, CA United States
MPEX PHARMACEUTICALS, INC. 6 Bridgewater, NJ United States
Raptor Pharmaceuticals Inc. 3 Novato, CA United States
Rempex Pharmaceuticals, Inc. 3 Lincolnshire, IL United States
MELINTA SUBSIDIARY CORP. 3 Parsippany, NJ United States
MELINTA SUBSIDIARY CORP. 3 Morristown, NJ United States
Melinta Therapeutics Inc. 1 Morristown, NJ United States
Qpex Biopharma, Inc. 1 San Diego, CA United States

Recent patent applications by Griffith David C.

David C. Griffith from San Marcos, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-27

US20250064838A1

Human necessities

THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES

#2 | 2025-02-13

US20250049820A1

Human necessities

TETRACYCLINE COMPOSITIONS

#3 | 2024-06-13

US20240189326A1

Human necessities

Tetracycline compositions

#4 | 2023-09-07

US20230277571A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#5 | 2023-05-18

US20230151029A1

Chemistry; metallurgy

BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF

#6 | 2022-04-28

US20220125813A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#7 | 2022-03-17

US20220080047A1

Human necessities

TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION

#8 | 2022-02-17

US20220047604A1

Human necessities

AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF

#9 | 2021-07-29

US20210228589A1

Human necessities

USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS

#10 | 2021-04-29

US20210121472A1

Human necessities

AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS

#11 | 2021-02-25

US20210052608A1

Human necessities

METHODS OF TREATING BACTERIAL INFECTIONS WITH MINOCYCLINE

#12 | 2020-07-16

US20200222434A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#13 | 2020-05-14

US20200147111A1

Human necessities

Cyclic boronic acid ester derivatives and therapeutic uses thereof

#14 | 2020-01-02

US20200000828A1

Human necessities

Tetracycline compositions

#15 | 2020-01-02

US20200000817A1

Human necessities

Use of aerosolized levofloxacin for treating cystic fibrosis

#16 | 2019-12-19

US20190381057A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

#17 | 2019-10-24

US20190321371A1

Human necessities

Aerosol fluoroquinolone formulations for improved pharmacokinetics

#18 | 2019-04-11

US20190105337A1

Human necessities

METHODS OF TREATING BACTERIAL INFECTIONS

#19 | 2019-03-14

US20190076449A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#20 | 2018-08-02

US20180214465A1

Human necessities

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#21 | 2018-07-26

US20180207183A1

Human necessities

Pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#22 | 2018-04-19

US20180104252A1

Human necessities

Aerosol fluoroquinolone formulations for improved pharmacokinetics

#23 | 2018-03-29

US20180085462A1

Human necessities

Topical use of levofloxacin for reducing lung inflammation

#24 | 2018-03-29

US20180085376A1

Human necessities

Use of aerosolized levofloxacin for treating cystic fibrosis

#25 | 2018-03-22

US20180078570A1

Human necessities

TETRACYCLINE COMPOSITIONS

#26 | 2018-03-15

US20180071325A1

Human necessities

Cyclic boronic acid ester derivatives and methods of making the same

#27 | 2017-08-24

US20170239323A1

Human necessities

ORITAVANCIN FORMULATIONS

#28 | 2016-11-24

US20160339045A1

Human necessities

METHODS OF TREATING BACTERIAL INFECTIONS

#29 | 2016-10-06

US20160287606A1

Human necessities

Aerosol fluoroquinolone formulations for improved pharmacokinetics

#30 | 2016-09-29

US20160279138A1

Human necessities

AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF

#31 | 2016-08-04

US20160220591A1

Human necessities

Cyclic boronic acid ester derivatives and therapeutic uses thereof

#32 | 2015-04-02

US20150094282A1

Human necessities

Tetracycline compositions

#33 | 2014-11-06

US20140329810A1

Human necessities

Aerosol fluoroquinolone formulations for improved pharmacokinetics

#34 | 2014-07-10

US20140194393A1

Human necessities

Tetracycline compositions

#35 | 2014-04-17

US20140105985A1

Human necessities

TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION

#36 | 2014-03-06

US20140066441A1

Human necessities

AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF

#37 | 2013-12-26

US20130345172A1

Chemistry; metallurgy

Cyclic boronic acid ester derivatives and therapeutic uses thereof

#38 | 2013-12-12

US20130331355A1

Human necessities

Cyclic boronic acid ester derivatives and therapeutic uses thereof

#39 | 2012-11-01

US20120276153A1

Human necessities

Use of aerosolized levofloxacin for treating cystic fibrosis

#40 | 2012-09-20

US20120237564A1

Human necessities

Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease

#41 | 2012-08-23

US20120213707A1

Human necessities

Riboflavin Based Aerosol and Use as Placebo in Trials

#42 | 2012-02-16

US20120040932A1

Human necessities

Cyclic boronic acid ester derivatives and therapeutic uses thereof

#43 | 2010-07-01

US20100166673A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

#44 | 2010-06-24

US20100158957A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

#45 | 2010-04-08

US20100087416A1

Human necessities

Aerosol fluoroquinolone formulations for improved pharmacokinetics

#46 | 2010-04-08

US20100087386A1

Human necessities

Topical use of Levofloxacin for reducing lung inflammation

#47 | 2010-02-18

US20100040560A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

#48 | 2010-02-18

US20100037890A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

#49 | 2006-12-07

US20060276483A1

Human necessities

Aerosolized fluoroquinolones and uses thereof

InventorID:

568475 ⎘